Product NDC: | 0031-8742 |
Proprietary Name: | Robitussin Peak Cold Multi-Symptom Cold |
Non Proprietary Name: | dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride |
Active Ingredient(s): | 10; 100; 5 mg/5mL; mg/5mL; mg/5mL & nbsp; dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0031-8742 |
Labeler Name: | Richmond Division of Wyeth |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20110612 |
Package NDC: | 0031-8742-20 |
Package Description: | 1 BOTTLE in 1 CARTON (0031-8742-20) > 237 mL in 1 BOTTLE |
NDC Code | 0031-8742-20 |
Proprietary Name | Robitussin Peak Cold Multi-Symptom Cold |
Package Description | 1 BOTTLE in 1 CARTON (0031-8742-20) > 237 mL in 1 BOTTLE |
Product NDC | 0031-8742 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20110612 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Richmond Division of Wyeth |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 10; 100; 5 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes |